Home › Funds › Affinity Asset Advisors, LLC › FBRX

Affinity Asset Advisors, LLC position in FBRX

FORTE BIOSCIENCES INC

Affinity Asset Advisors, LLC reported holding 1,145,391 shares of FBRX (FORTE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$24.3M, representing 1.17% of its reported portfolio and ranking #26 among its reported holdings. Affinity Asset Advisors, LLC has disclosed FBRX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.15M sh
Reported value held$24.34M
Portfolio Weight1.17%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's FBRX position evolved

Affinity Asset Advisors, LLC first disclosed a stake in FBRX in Q4 2025 at 22,400 shares (US$611K). The position peaked in Q1 2026 at 1,011,890 shares, worth US$26.2M. Across 3 filings, Affinity Asset Advisors, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,145,391 shares valued at US$24.3M — an increase of 133,501 shares quarter over quarter.. Notable position changes include a 4417% increase in Q1 2026.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 22.40K $610.85K New
Q1 2026 1.01M $26.21M Add
Q2 2026 1.15M $24.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FBRX and 13F data

FBRX (FORTE BIOSCIENCES INC) is a company whose sector is not yet classified in our data. 70 other funds we track also report a position in FBRX — the largest reported positions include ORBIMED ADVISORS LLC (US$33.5M), MPM BioImpact LLC (US$21.0M), TCG Crossover Management, LLC (US$19.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FBRX

All FBRX fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held FBRX?

Affinity Asset Advisors, LLC has disclosed FBRX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Affinity Asset Advisors, LLC's current position in FBRX?

As of Q2 2026, Affinity Asset Advisors, LLC holds 1.15M shares of FBRX (FORTE BIOSCIENCES INC), valued at $24.34M, representing 1.17% of its reported portfolio and ranking #26.

Has Affinity Asset Advisors, LLC been buying or selling FBRX?

In the latest 13F filing (Q2 2026), Affinity Asset Advisors, LLC increased its position in FBRX. The position peaked in Q1 2026 at 1.01M shares.

Which other funds hold FBRX?

Other major institutional holders of FBRX include ORBIMED ADVISORS LLC, MPM BioImpact LLC, TCG Crossover Management, LLC, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.